Share on StockTwits

Investment analysts at Roth Capital initiated coverage on shares of Ampliphi Biosciences Corp (NASDAQ:APHB) in a note issued to investors on Thursday, reports. The firm set a “buy” rating on the stock.

Ampliphi Biosciences Corp (NASDAQ:APHB) opened at 0.59 on Thursday. Ampliphi Biosciences Corp has a 52 week low of $0.10 and a 52 week high of $0.74. The stock has a 50-day moving average of $0.56 and a 200-day moving average of $0.53. The company’s market cap is $107.7 million.

The Fly On The Wall

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.